Renaissance Technologies (RenTech)'s ASND Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 117,332 shares of Ascendis Pharma A/S (ASND) worth $26.84 M, representing 0.04% of the portfolio. First purchased in 2017-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ASND, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 117,332 shares. Largest reduction occurred in Q3 2019, reducing 105,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Ascendis Pharma A/S (ASND) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ascendis Pharma A/S (ASND) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +117,332 | New Buy | 117,332 | $228.73 |
| Q3 2023 | -82,699 | Sold Out | 0 | $0.00 |
| Q2 2023 | +82,699 | New Buy | 82,699 | $0.09 |
| Q3 2020 | -55,082 | Sold Out | 0 | $0.00 |
| Q2 2020 | +4,004 | Add 7.84% | 55,082 | $147.91 |
| Q1 2020 | +21,235 | Add 71.16% | 51,078 | $112.61 |
| Q4 2019 | -44,756 | Reduce 60.00% | 29,843 | $139.13 |
| Q3 2019 | -105,200 | Reduce 58.51% | 74,599 | $96.31 |
| Q2 2019 | +91,000 | Add 102.48% | 179,799 | $115.15 |
| Q1 2019 | +88,799 | New Buy | 88,799 | $117.70 |
| Q4 2018 | -41,900 | Sold Out | 0 | $0.00 |
| Q3 2018 | -14,600 | Reduce 25.84% | 41,900 | $70.86 |
| Q2 2018 | +49,860 | Add 750.90% | 56,500 | $66.51 |
| Q1 2018 | -8,860 | Reduce 57.16% | 6,640 | $65.36 |
| Q4 2017 | -18,000 | Reduce 53.73% | 15,500 | $40.06 |
| Q3 2017 | +8,030 | Add 31.53% | 33,500 | $36.24 |
| Q2 2017 | +25,470 | New Buy | 25,470 | $27.76 |
Renaissance Technologies (RenTech)'s Ascendis Pharma A/S Investment FAQs
Renaissance Technologies (RenTech) first purchased Ascendis Pharma A/S (ASND) in Q2 2017, acquiring 25,470 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Ascendis Pharma A/S (ASND) for 17 quarters since Q2 2017.
Renaissance Technologies (RenTech)'s largest addition to Ascendis Pharma A/S (ASND) was in Q1 2026, adding 117,332 shares worth $26.84 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 117,332 shares of Ascendis Pharma A/S (ASND), valued at approximately $26.84 M.
As of the Q1 2026 filing, Ascendis Pharma A/S (ASND) represents approximately 0.04% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Ascendis Pharma A/S (ASND) was 179,799 shares, as reported at the end of Q2 2019.